AI Regulation in Healthcare: Preparing for Increased Enforcement and Compliance

Introduction

Healthcare organizations leveraging artificial intelligence technologies face a new reality of regulatory scrutiny. Jeff Wurzburg, healthcare partner at Norton Rose Fulbright, warns that enforcement around AI in healthcare is still in its early stages but will increase significantly in the years ahead. This regulatory oversight won't come from a new AI-specific regulator but will mature through existing payment and oversight frameworks that healthcare organizations already navigate daily.

For defenders and security leaders, this represents both a challenge and an imperative. AI systems in healthcare environments must now be treated with the same governance rigor as other regulated clinical systems, yet most organizations lack the visibility and controls necessary to demonstrate compliance when regulators come calling.

Technical Analysis

The Regulatory Landscape

Unlike traditional cybersecurity threats with clear CVE identifiers, AI regulatory risk presents a different challenge. The enforcement mechanisms will likely leverage:

CMS (Centers for Medicare & Medicaid Services) compliance programs
OCR (Office for Civil Rights) HIPAA enforcement authority
FDA existing medical device regulatory pathways
State Attorney General consumer protection authorities

These frameworks will increasingly demand that healthcare organizations demonstrate:

AI Model Inventory: Complete visibility into all AI models deployed in production environments, including third-party vendor tools embedded in EHR systems
Risk-Based Classification: Documentation of risk assessments tied to clinical decision-making impact, patient data handling, and potential for bias
Audit Trails: Comprehensive logging of AI system inputs, outputs, and decision pathways sufficient for retrospective analysis
Monitoring and Governance: Operational controls to detect AI model drift, adversarial inputs, or inappropriate use cases

Current Exposure

Healthcare organizations face immediate risk in several areas:

Black Box Algorithms: Proprietary AI solutions from vendors that cannot explain their decision-making logic
Shadow AI: Departments deploying AI tools without IT/security review
Data Governance: Using patient data to train models without appropriate consent or de-identification
Clinical Decision Support: AI tools making or informing patient care decisions without clinical validation

Executive Takeaways

1. Establish an AI Governance Framework Now

Before regulators enforce specific standards, implement a governance structure that documents all AI deployments across the organization. This should include:

An AI model inventory tracking all tools from pilot to production
Risk categorization based on clinical impact and data sensitivity
Approval workflows for new AI implementations
Roles and responsibilities for AI accountability

2. Map AI Systems to Existing Compliance Frameworks

Rather than waiting for AI-specific regulations, map current AI implementations to existing obligations:

HIPAA Security Rule requirements for protected health information processing
FDA medical device classification for AI that influences clinical decisions
CMS conditions of participation for automated decision-making in care delivery
State breach notification laws covering AI-related data exposures

3. Implement Technical Controls for AI Accountability

Deploy monitoring and logging capabilities to enable auditability:

Centralized logging of AI system inputs/outputs
Anomaly detection for unusual AI behavior or outcomes
Version control for AI model configurations
Immutable audit trails for AI-influenced clinical decisions

4. Validate Vendor AI Claims Through Testing

Conduct independent validation of third-party AI tools:

Request model explainability documentation
Test for potential bias against protected patient populations
Verify data handling and storage practices
Establish service level expectations for model performance monitoring

5. Prepare for Regulatory Inquiry with Documentation

Develop readiness for inevitable regulatory inquiries:

Create pre-written response templates for common AI regulatory questions
Establish evidentiary standards for AI model performance and governance
Conduct tabletop exercises simulating AI-related enforcement actions

6. Build Clinical and Security Collaboration

Foster partnerships between clinical, security, and compliance teams:

Establish cross-functional AI review committees
Train security analysts on AI-specific risks and monitoring
Equip clinical leadership with foundational AI literacy for governance decisions

Remediation

Immediate Actions (Next 90 Days)

Complete AI Inventory Assessment: Survey all departments to identify AI tools in use, including embedded features in existing software products
Classify AI Risk Levels: Categorize identified AI systems by clinical impact, data sensitivity, and regulatory exposure
Develop Documentation Standards: Create templates for AI system documentation including purpose, data sources, validation methods, and monitoring plans

Medium-Term Initiatives (Next 6 Months)

Implement AI Monitoring: Deploy technical controls to log and analyze AI system performance and outcomes
Enhance Vendor Management: Update procurement processes to include specific AI governance requirements for new technology purchases
Conduct AI-Specific Risk Assessment: Evaluate current AI deployments against regulatory expectations and industry best practices

Long-Term Strategy (Next 12-18 Months)

Establish Center of Excellence: Create a dedicated team for AI governance that spans clinical, technical, and compliance functions
Develop Regulatory Relationships: Engage proactively with regulators and industry groups to stay ahead of evolving requirements
Build AI Validation Capability: Develop internal capacity to independently validate AI model performance and safety

Related Resources

Security Arsenal Healthcare Cybersecurity AlertMonitor Platform Book a SOC Assessment healthcare Intel Hub